• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

    1/22/21 3:54:10 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email
    For Immediate Release:
    January 22, 2021

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

    • The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found that in a variety of online postings from as early as March 2020, the defendant, Johnny T. Stine, claimed to have a COVID-19 vaccine that he offered to inject in customers for $400-$1000 each. Stine’s company, North Coast Biologics, had previously received a warning letter from the agency for promoting an unapproved COVID-19 vaccine product.

      “Unproven injectable vaccines purported to prevent or treat COVID-19, made from unknown substances under unknown conditions, present significant health risks in and of themselves. They also can lead consumers to make lifestyle choices that increase their actual risk of infection with COVID-19, or to delay or stop appropriate medical treatment,” said Special Agent in Charge Lisa L. Malinowski, FDA Office of Criminal Investigations Los Angeles Field Office. “The FDA will continue to investigate fraudulent COVID-19 treatments and bring to justice those who try to profit from the pandemic by offering unproven and illegally marketed coronavirus products.”
    • The FDA is reissuing the Emergency Use Authorizations (EUAs) for decontamination systems that are authorized to decontaminate compatible N95 respirators for use by healthcare personnel (HCP) to prevent exposure to pathogenic biological airborne particulates when there is an insufficient supply of new respirators resulting from the Coronavirus Disease 2019 (COVID-19) pandemic. Among other things, the reissued EUAs for certain decontamination systems are now only authorized to decontaminate each compatible N95 respirator a maximum of four or fewer times.

      Based on the FDA’s review of real-world use of these systems and evidence from adverse events and scientific literature, including studies regarding N95 respirator failures from simulated and real-world use, the FDA has determined that it is appropriate to protect the public health or safety to revise certain decontamination system EUAs to limit the number of decontamination cycles and respirator reuses permitted under each authorization.
    • Today, the FDA also added two new devices to the device discontinuance list on our web page that lists medical device shortages during the COVID-19 public health emergency. There are no updates to the device shortage list at this time. The FDA will continue to update the device shortage and device discontinuance lists as the COVID-19 public health emergency evolves. Specifically, the FDA added the following devices to the device discontinuance list:
      • 3M Company's 3M Triple Layer Molded Face Mask (2042F) and 3M Triple Layer Molded Face Mask, Petite (2042FP)
      • BioFire Diagnostics, LLC's FilmArray Instrument (FLM1-ASY-0001)
    • Testing updates:
      • As of today, 319 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs). These include 237 molecular tests and sample collection devices, 69 antibody tests, and 13 antigen tests. There are 33 molecular authorizations that can be used with home-collected samples. There is one molecular prescription at-home test, one antigen prescription at-home test, and one over-the-counter (OTC) at-home antigen test.

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

    ###


    Inquiries

    Media:
    Abby Capobianco
    888-INFO-FDA
    Consumer:
    888-INFO-FDA

    Related Information

    Related Information
    • FAQs on Testing for SARS-CoV-2
    • Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)
    • Coronavirus Disease 2019 (COVID-19)

    Get the next $MMM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    10/22/2024Hold → Buy
    Melius
    9/6/2024$125.00Underweight
    Morgan Stanley
    7/30/2024$145.00Hold → Buy
    Argus
    7/29/2024$110.00 → $150.00Hold → Buy
    Deutsche Bank
    6/13/2024$125.00Peer Perform → Outperform
    Wolfe Research
    6/7/2024$105.00 → $120.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $MMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • 3M upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded 3M from Equal Weight to Overweight and set a new price target of $170.00 from $140.00 previously

      1/22/25 7:45:34 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M upgraded by UBS with a new price target

      UBS upgraded 3M from Neutral to Buy and set a new price target of $184.00

      11/13/24 8:05:47 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M upgraded by Melius

      Melius upgraded 3M from Hold to Buy

      10/22/24 11:24:35 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • 3M Announces Upcoming Investor Event

      ST. PAUL, Minn., April 30, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today announced the following investor event: BofA Securities Industrials, Transportation & Airlines Key Leaders Conference on Wednesday, May 14, 2025. William Brown, Chairman and Chief Executive Officer will speak at 8:45 a.m. ET.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com. About 3M3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn

      4/30/25 10:10:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Reports First-Quarter 2025 Results

      GAAP sales of $6.0 billion, down 1.0% YoY; operating margin 20.9%, up 180 bps YoY; EPS of $2.04, up 61% YoYAdjusted sales of $5.8 billion with organic growth of 1.5% YoYAdjusted operating margin of 23.5%, up 220 bps YoYAdjusted EPS of $1.88, up 10% YoYOperating cash flow of $(0.1) billion with adjusted free cash flow of $0.5 billionUpdated 2025 guidance and providing tariff sensitivityST. PAUL, Minn., April 22, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter 2025 results. "We had strong results in the first quarter with positive organic sales growth, margins ahead of expectations and double-digit EPS growth," said William Brown, 3M Chairman and Chief Executive Officer. "In th

      4/22/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • FUTURO Brand just got an upgrade with movement in mind

      Relieve muscle and joint stiffness, soreness and swelling with our new compression sleeves that deliver comfortable wear all day long. ST. PAUL, Minn., April 16, 2025 /PRNewswire/ -- FUTURO™ Brand introduces a collection of redesigned premium compression sleeves for muscle and joint support. The new sleek look, smooth low-profile construction and ultra-soft fabric with four-way stretch delivers an unrestricted, comfortable fit, flexibility and range of motion. Prioritizing all day comfort and wear, a no-cutout construction helps reduce chafing and rubbing and an innovative comfort band with silicone beading helps prevent slipping and rolling. The reengineered compression sleeves, supported b

      4/16/25 12:13:00 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Financials

    Live finance-specific insights

    See more
    • 3M Reports First-Quarter 2025 Results

      GAAP sales of $6.0 billion, down 1.0% YoY; operating margin 20.9%, up 180 bps YoY; EPS of $2.04, up 61% YoYAdjusted sales of $5.8 billion with organic growth of 1.5% YoYAdjusted operating margin of 23.5%, up 220 bps YoYAdjusted EPS of $1.88, up 10% YoYOperating cash flow of $(0.1) billion with adjusted free cash flow of $0.5 billionUpdated 2025 guidance and providing tariff sensitivityST. PAUL, Minn., April 22, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter 2025 results. "We had strong results in the first quarter with positive organic sales growth, margins ahead of expectations and double-digit EPS growth," said William Brown, 3M Chairman and Chief Executive Officer. "In th

      4/22/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Announces Upcoming Investor Event

      ST. PAUL, Minn., Apr. 8, 2025 /PRNewswire/ -- 3M (NYSE: MMM) today announced the following investor event: First-quarter 2025 earnings conference call on Tuesday, Apr. 22, 2025, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com. About 3M3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news. Investor Contact:Diane Farrow

      4/8/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Provides Medium-Term Financial Outlook at 2025 Investor Day; Presents Strategic Priorities that Will Drive Growth, Operational Excellence, and Return Cash to Shareholders

      Highlights innovation and commercial excellence initiatives that will accelerate sales growth to outperform macroOutlines operational excellence strategies to drive margin expansion, earnings growth, and strong free cash flowProvides balanced capital deployment framework focused on investing in the business and returning at least $10 billion in cash to shareholders over the outlook periodST. PAUL, Minn., Feb. 26, 2025 /PRNewswire/ -- 3M (NYSE:MMM) will host its 2025 Investor Day today in St. Paul, Minnesota, beginning at 8 a.m. CST. During the event, 3M will provide its medium-term financial outlook, and leadership will discuss priorities that will deliver sustainable value creation. "3M is

      2/26/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/13/24 4:56:03 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/9/23 10:54:46 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/9/22 3:15:56 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Leadership Updates

    Live Leadership Updates

    See more
    • 3M Announces New Board Appointments

      William Brown to become Chairman of the Board of DirectorsMike Roman to retire as Executive Chairman and Director and become Executive Advisor to the BoardDavid Bozeman elected to the BoardAmy Hood does not intend to stand for reelectionST. PAUL, Minn., Feb. 10, 2025 /PRNewswire/ -- 3M (NYSE:MMM) announced today changes to its Board of Directors and Board leadership structure. William M. "Bill" Brown, 3M's Chief Executive Officer and Director, has been appointed by the Board to serve as its Chairman, effective March 1, 2025 in addition to his current responsibilities.  Michael F. Roman, Executive Chairman of the Board of Directors, has announced his intention to retire as Executive Chairman,

      2/10/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M joins consortium to accelerate semiconductor technology in the US

      ST. PAUL, Minn., Feb. 3, 2025  /PRNewswire/ -- 3M is expanding its commitment to the semiconductor industry by joining the US-JOINT Consortium, a strategic partnership of 12 leading semiconductor suppliers. The consortium drives research and development in next-generation semiconductor advanced packaging and back-end processing technologies anchored by a new cutting-edge facility in Silicon Valley. "As the demands of AI and other high performance computing technologies increase, suppliers must work together to provide comprehensive solutions to tough challenges on increasingly

      2/3/25 10:55:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M's "Green Works" docuseries spotlights how green jobs can help drive a more sustainable future

      3M's docuseries debuts at Fast Company Innovation Festival ahead of New York Climate WeekCollaboration with Work on Climate will address the critical need for more green talent and provide resources for professionals3M to emphasize importance of inspiring the workforce, closing the skills gap and developing a green economy talent pipeline during New York Climate Week eventsST. PAUL, Minn., Sept. 18, 2024 /PRNewswire/ -- 3M is premiering a new global docuseries today, "Green Works," to spotlight individuals working to address climate challenges and the critical need for more talent to support the green transition. The film, produced by 3M in partnership with Generous Films, features five indi

      9/18/24 3:00:00 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Pilz Torsten

      3 - 3M CO (0000066740) (Issuer)

      5/7/25 12:29:26 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • Sr Vice President & CAO Reinseth Theresa E covered exercise/tax liability with 441 shares and exercised 1,441 shares at a strike of $142.08, increasing direct ownership by 20% to 6,008 units (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/5/25 8:35:54 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • Chairman & CEO Brown William M exercised 8,577 shares at a strike of $142.08 and covered exercise/tax liability with 3,912 shares (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/5/25 8:24:22 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

      For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

      1/22/21 3:54:10 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    SEC Filings

    See more
    • SEC Form 10-Q filed by 3M Company

      10-Q - 3M CO (0000066740) (Filer)

      4/22/25 12:24:49 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - 3M CO (0000066740) (Filer)

      4/22/25 6:36:10 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by 3M Company

      DEFA14A - 3M CO (0000066740) (Filer)

      3/28/25 4:02:11 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care